Dr. Yifan Pang, MD

Dr. Pang practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Pang's NPI, 1952758435, was assigned on May 16, 2016. Dr. Pang holds North Carolina license 2022-01560.

Dr. Pang's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Pang's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Pang is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Levine Cancer Institute. Dmand AI also links Dr. Pang to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pang practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Pang's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Pang is licensed in North Carolina.

CMS data shows 214 Medicare services from Dr. Pang across 3 procedure codes in 2024, all of them office visits, for 71 Medicare patients. Medicare paid $15,656 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 71 Medicare patients who saw Dr. Pang in 2024. The largest group is 65 to 74, with 36 patients. 72% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pang's median patient age at 71, with 39% women.

In 2024, Dr. Pang wrote 663 Medicare Part D claims for 80 patients. 83% of them were for generic drugs. CMS names the drug for 414 of them, across 15 drugs with 11 or more claims each, at $876,893 in total drug cost. In 2023, CMS named 293 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Pang for performance year 2024, reported as part of a group. Dr. Pang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pang as offering telehealth.

CMS Open Payments shows 10 general payments to Dr. Pang from 7 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 77% of the total. Syndax Pharmaceuticals, Inc. paid the most, $3,866.